Daniel James Ford,Richard Jeremy Franklin,Anant Ramrao Ghawalkar,Helen Tracey Horsley,Qiuya Huang,James Thomas Reuberson,Bart Vanderhoydonck
申请号:
US14650771
公开号:
US09714248B2
申请日:
2013.12.20
申请国别(地区):
US
年份:
2017
代理人:
摘要:
A series of pyrazolo[3,4-d]pyrimidine derivatives that are substituted at the 4-position by a diaza monocyclic, bridged bicyclic or spirocyclic moiety, are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders viral diseases and malaria and organ and cell transplant rejection.